GlaxoSmithKline (LSE:GSK)
GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
{{ formattedPrice }} {{ change }} (-0.12%)
Quotes delayed. Last trade: 18-06-2018, 04:37:29pm BST
| Open Price | {{ openPrice }} | Close Price | {{ closePrice }} |
| Day High | {{ high }} | Day Low | {{ low }} |
| Bid | {{ bid }} | Ask | {{ ask }} |
| Volume | 0 |
Related Articles
-
Why the GSK share price should smash the FTSE 100 this year
Roland Head takes a look at FTSE 100 (INDEXFTSE:UKX) climber GlaxoSmithKline plc (LON:GSK) and highlights another turnaround opportunity. Read More »
-
Is GSK’s share price the Footsie bargain of 2018?
Does GlaxoSmithKline plc (LON: GSK) offer a potent risk/reward ratio for the long term? Read More »
-
Why I’d still buy FTSE 100 giant GlaxoSmithKline but avoid this growth stock
G A Chester sees reasons to shun a small-cap growth stock with an uncertain outlook in favour of GlaxoSmithKline plc (LON:GSK). Read More »
-
Why I’d buy this growth stock alongside GlaxoSmithKline
Defensive dividend income from GlaxoSmithKline plc (LON: GSK) could complement this stock’s growth potential. Read More »
-
2 stocks I’d buy and hold for the next 20 years
If you had to decide on 2 shares to buy now but were not allowed to sell them for 20 years, what would you... Read More »
-
GlaxoSmithKline’s share price and 5% dividend yield make it my buy of the decade
Harvey Jones says the combination of a cut price valuation and 5% plus yield make GlaxoSmithKline plc (LON: GSK) a rare opportunity for long-term... Read More »
-
Why GlaxoSmithKline’s share price could be about to skyrocket
A 5%+ yield, double-digit profit growth, improving balance sheet and dirt-cheap valuation put GlaxoSmithKline plc (LON: GSK) in a fantastic position. Read More »
-
GlaxoSmithKline’s share price is rising. Is it time to buy?
GlaxoSmithKline plc's (LON: GSK) share price has bounced 10% in the last few weeks. Is now the time to take a closer look at... Read More »
-
Why I believe the GlaxoSmithKline share price is now too cheap to ignore
I believe the GlaxoSmithKline plc (LON: GSK) share price can only go up from here. Read More »
-
GlaxoSmithKline plc isn’t the only pharma stock I’d buy today
Royston Wild explains why GlaxoSmithKline plc (LON: GSK) isn't the only pharma star that could make you a fortune. Read More »
